SCHEMBL19082199

SCHEMBL19082199

c1ccc(-c2ccc3cc(-c4c5ccccc5c(-c5ccc6c(c5)sc5ccc7sc8c9ccccc9ccc8c7c56)c5ccccc45)ccc3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 4/20 0.42
CYP1B1 Q16678 4/20 0.42
F9 P00740 3/20 0.39
LIMK1 P53667 2/20 0.39
CYP1A2 P05177 2/20 0.36
MCL1 Q07820 1/20 0.35
ESR1 P03372 4/20 0.35
ESR2 Q92731 4/20 0.35
PIK3CA P42336 1/20 0.33
PI4KA P42356 1/20 0.33
PI4KB Q9UBF8 1/20 0.33
F10 P00742 1/20 0.32
MAPK9 P45984 1/20 0.32
MAPK14 Q16539 1/20 0.32
CDK4 P11802 2/20 0.32
CCND1 P24385 2/20 0.32
GPR84 Q9NQS5 1/20 0.32
S1PR4 O95977 1/20 0.32
S1PR5 Q9H228 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082344 0.97 CYP1A1 (0.42) CYP1A1CYP1B1F9LIMK1CYP1A2
SCHEMBL19082283 0.95 CYP1A1 (0.36) CYP1A1CYP1B1F9LIMK1CYP1A2
SCHEMBL19082214 0.95 CYP1A1 (0.44) CYP1A1CYP1B1F9LIMK1CYP1A2
SCHEMBL19082197 0.94 CYP1A1 (0.41) CYP1A1CYP1B1F9LIMK1CYP1A2
SCHEMBL19082095 0.94 CYP1A1 (0.45) CYP1A1CYP1B1F9LIMK1CYP1A2
SCHEMBL19082130 0.94 CYP1A1 (0.39) CYP1A1CYP1B1LIMK1CYP1A2ESR1
SCHEMBL19082263 0.93 CYP1A1 (0.45) CYP1A1CYP1B1F9LIMK1CYP1A2
SCHEMBL19082338 0.91 CYP1A1 (0.41) CYP1A1CYP1B1F9LIMK1CYP1A2
SCHEMBL17944275 0.91 F9 (0.42) CYP1A1CYP1B1F9LIMK1CYP1A2
SCHEMBL19082340 0.90 CYP1A1 (0.42) CYP1A1CYP1B1F9LIMK1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885F9 1203/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885F9 1203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.